New Treatments for Asthma

Jenny Huang; Milind Pansare

doi:10.1016/j.pcl.2019.06.001

New Treatments for Asthma

Jenny Huang, Milind Pansare

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Abstract

Asthma is a complex, heterogeneous chronic airway disease with high prevalence of uncontrolled disease. New therapies, including biologics, are now available to treat T2 high asthma. Treatment of T2 low asthma remains a challenge. Asthma guidelines need be to updated to incorporate new therapeutics.

Original language	English
Pages (from-to)	925-939
Number of pages	15
Journal	Pediatric Clinics of North America
Volume	66
Issue number	5
DOIs	https://doi.org/10.1016/j.pcl.2019.06.001
State	Published - Oct 2019

Keywords

Asthma endotypes
Biologics
Bronchial thermoplasty
Long-acting antimuscarinic agents
Severe asthma

Access to Document

10.1016/j.pcl.2019.06.001

Cite this

@article{1afd78311bb9488b8a8d387a78b43c1d,

title = "New Treatments for Asthma",

abstract = "Asthma is a complex, heterogeneous chronic airway disease with high prevalence of uncontrolled disease. New therapies, including biologics, are now available to treat T2 high asthma. Treatment of T2 low asthma remains a challenge. Asthma guidelines need be to updated to incorporate new therapeutics.",

keywords = "Asthma endotypes, Biologics, Bronchial thermoplasty, Long-acting antimuscarinic agents, Severe asthma",

author = "Jenny Huang and Milind Pansare",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = oct,

doi = "10.1016/j.pcl.2019.06.001",

language = "English",

volume = "66",

pages = "925--939",

journal = "Pediatric Clinics of North America",

issn = "0031-3955",

number = "5",

}

TY - JOUR

T1 - New Treatments for Asthma

AU - Huang, Jenny

AU - Pansare, Milind

PY - 2019/10

Y1 - 2019/10

N2 - Asthma is a complex, heterogeneous chronic airway disease with high prevalence of uncontrolled disease. New therapies, including biologics, are now available to treat T2 high asthma. Treatment of T2 low asthma remains a challenge. Asthma guidelines need be to updated to incorporate new therapeutics.

AB - Asthma is a complex, heterogeneous chronic airway disease with high prevalence of uncontrolled disease. New therapies, including biologics, are now available to treat T2 high asthma. Treatment of T2 low asthma remains a challenge. Asthma guidelines need be to updated to incorporate new therapeutics.

KW - Asthma endotypes

KW - Biologics

KW - Bronchial thermoplasty

KW - Long-acting antimuscarinic agents

KW - Severe asthma

UR - http://www.scopus.com/inward/record.url?scp=85071133356&partnerID=8YFLogxK

U2 - 10.1016/j.pcl.2019.06.001

DO - 10.1016/j.pcl.2019.06.001

M3 - Review article

C2 - 31466682

AN - SCOPUS:85071133356

SN - 0031-3955

VL - 66

SP - 925

EP - 939

JO - Pediatric Clinics of North America

JF - Pediatric Clinics of North America

IS - 5

ER -

New Treatments for Asthma

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this